Evidence map›Paper›PMID 36347927›Full record

ArticleScientific reports2022

Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.

Yuka Asami, Kengo Hiranuma, Daisuke Takayanagi, Maiko Matsuda, Yoko Shimada, Mayumi Kobayashi Kato, Ikumi Kuno, Naoya Murakami, Masaaki Komatsu, Ryuji Hamamoto and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Yuka AsamiDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Kengo HiranumaDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Daisuke TakayanagiDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Maiko MatsudaDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Yoko ShimadaDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Mayumi Kobayashi KatoDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Ikumi KunoDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Naoya MurakamiDepartment of Radiation Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Masaaki KomatsuDivision of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Ryuji HamamotoDivision of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Takashi KohnoDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Akihiko SekizawaDepartment of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Koji MatsumotoDepartment of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Tomoyasu KatoDepartment of Gynecology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Hiroshi YoshidaDivision of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. hiroyosh@ncc.go.jp.
Kouya ShiraishiDivision of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. kshirais@ncc.go.jp.
National Cancer Centre Japan · JPShowa University · JPTokyo National Hospital · JPRIKEN Center for Advanced Intelligence Project · JPJuntendo University · JPNational Cancer Center Hospital East · JP

Funding

Grant-in-Aid for Scientific Research (C) 20K09636Grant-in-Aid for Young Scientists (B) 19K16572Grant-in-Aid for Young Scientists (B) 20K18207National Cancer Center Research and Development Fund 2020-J-2
6 · The paper itself

Abstract

Lymph node metastasis (LNM) is a well-established prognostic factor in endometrial cancer (EC). We aimed to construct a model that predicts LNM and prognosis using preoperative factors such as myometrial invasion (MI), enlarged lymph nodes (LNs), histological grade determined by endometrial biopsy, and serum cancer antigen 125 (CA125) level using two independent cohorts consisting of 254 EC patients. The area under the receiver operating characteristic curve (AUC) of the constructed model was 0.80 regardless of the machine learning techniques. Enlarged LNs and higher serum CA125 levels were more significant in patients with low-grade EC (LGEC) and LNM than in patients without LNM, whereas deep MI and higher CA125 levels were more significant in patients with high-grade EC (HGEC) and LNM than in patients without LNM. The predictive performance of LNM in the HGEC group was higher than that in the LGEC group (AUC = 0.84 and 0.75, respectively). Patients in the group without postoperative pathological LNM and positive LNM prediction had significantly worse relapse-free and overall survival than patients with negative LNM prediction (log-rank test, P < 0.01). This study showed that preoperative clinicopathological factors can predict LNM with high precision and detect patients with poor prognoses. Furthermore, clinicopathological factors associated with LNM were different between HGEC and LGEC patients.

Indexed as

Endometrial NeoplasmsLymph NodesFemaleHumansLymphatic MetastasisNeoplasm Recurrence, LocalPrognosisRetrospective Studies

Identifiers

PMID36347927
PMCPMC9643353
OpenAlexW4308573589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.